Andrews Julie 4

What Happened Julie Andrews, Chief Financial Officer of Orthofix Medical Inc. (OFIX), sold a total of 4,788 shares in two open-market sell transactions to satisfy tax withholding obligations related to the settlement of restricted stock units. On 2026-03-04 she sold 2,425 shares at a weighted-average price of $12.92 for proceeds of $31,322, and on 2026-03-05 she sold 2,363 shares at a weighted-average price of $12.55 for proceeds of $29,658 — about $60,980 total. These sales were made under a pre-existing sell-to-cover requirement and were executed without the reporting person's discretion.

Key Details

• Transaction dates and prices:
  • 2026-03-04: 2,425 shares sold, weighted-average price $12.92 (individual prices ranged $12.80–$13.03; see footnote F2).
  • 2026-03-05: 2,363 shares sold, weighted-average price $12.55 (individual prices ranged $12.48–$12.72; see footnote F4).
• Total shares sold: 4,788; total proceeds ≈ $60,980.
• Reason: Sell-to-cover to satisfy tax withholding on vested restricted stock units (footnote F1). Sale executed pursuant to a pre-existing plan and without the reporting person's discretion.
• Holdings note: Footnote F3 references 69,552 previously reported restricted stock units included in the reporting person's holdings.
• Filing timeliness: Form 4 filed 2026-03-06 for transactions on 2026-03-04 and 2026-03-05 — appears timely (filed within the required window).

Context

• These were routine sell-to-cover transactions to meet tax obligations tied to RSU settlement, not open-market discretionary sales. Such tax-withholding sales are common after RSU vesting and generally should not be interpreted on their own as a directional insider signal.